Backed by two leading medical journals, researchers propose a new plan to publish clinical trial data that pharmaceutical companies often try to bury.
Backed by two leading medical journals, researchers propose a new plan to publish clinical trial data that pharmaceutical companies often try to bury.
Leading medical and research centers around the world announce a plan to share massive amounts of genetic and clinical information.
Computational challenges are tapping the collective wisdom of the scientific community to solve medicine’s biggest problems.
The names and addresses of people participating in the Personal Genome Project can be easily tracked down despite such data being left off their online profiles.
Biotech entrepreneur Stephen Friend shares his thoughts on how cancer researchers can collaborate more effectively to achieve faster progress.
The regulatory body that licenses drugs for use in the European Union is devising a policy that will require the publication of some clinical trial data.
Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
Non-confirmatory or “negative” results are not worthless.
The largest collection of genetic and medical data in the United States links telomeres and genetic variants to longevity and disease.